Understanding successful development of complex health and healthcare interventions and its drivers from the perspective of developers and wider stakeholders: an international qualitative interview study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
30 05 2019
Historique:
entrez: 2 6 2019
pubmed: 4 6 2019
medline: 18 6 2020
Statut: epublish

Résumé

Identify how individuals involved in developing complex health and healthcare interventions (developers), and wider stakeholders in the endeavour, such as funders, define successful intervention development and what factors influence how interventions are developed. In-depth interviews with developers and wider stakeholders to explore their views and experiences of developing complex health and healthcare interventions. Interviews conducted with individuals in the UK, Europe and North America. Twenty-one individuals were interviewed: 15 developers and 6 wider stakeholders. Seventeen participants were UK based. Most participants defined successful intervention development as a process that resulted in effective interventions that were relevant, acceptable and could be implemented in real-world contexts. Accounts also indicated that participants aimed to develop interventions that end users wanted, and to undertake a development process that was methodologically rigorous and provided research evidence for journal publications and future grant applications. Participants' ambitions to develop interventions that had real-world impact drove them to consider the intervention's feasibility and long-term sustainability early in the development process. However, this process was also driven by other factors: the realities of resource-limited health contexts; prespecified research funder priorities; a reluctance to deviate from grant application protocols to incorporate evidence and knowledge acquired during the development process; limited funding to develop interventions and the need for future randomised controlled trials (RCTs) to prove effectiveness. Participants expressed concern that these drivers discouraged long-term thinking and the development of innovative interventions, and prioritised evaluation over development and future implementation. Tensions exist between developers' goal of developing interventions that improve health in the real world, current funding structures, the limited resources within healthcare contexts, and the dominance of the RCT for evaluation of these interventions. There is a need to review funding processes and expectations of gold standard evaluation.

Identifiants

pubmed: 31152042
pii: bmjopen-2018-028756
doi: 10.1136/bmjopen-2018-028756
pmc: PMC6549621
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e028756

Subventions

Organisme : Medical Research Council
ID : MR/K025643/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N015339/1
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Pilot Feasibility Stud. 2016 Mar 15;2:17
pubmed: 27965837
Am J Health Behav. 2016 Mar;40(2):155-71
pubmed: 26931748
Br J Health Psychol. 2019 May;24(2):334-356
pubmed: 30793445
Pilot Feasibility Stud. 2019 Mar 12;5:41
pubmed: 30923626
J Epidemiol Community Health. 2016 May;70(5):520-5
pubmed: 26573236
PLoS One. 2017 Mar 30;12(3):e0174438
pubmed: 28358821
Qual Quant. 2018;52(4):1893-1907
pubmed: 29937585
Health Psychol. 2014 May;33(5):465-74
pubmed: 23730717
Soc Sci Med. 2018 Aug;210:2-21
pubmed: 29331519
BMJ Open. 2017 Jul 11;7(7):e014650
pubmed: 28701409
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
Pilot Feasibility Stud. 2015 Oct 26;1:36
pubmed: 27965814
BMJ. 2016 Aug 23;354:i4536
pubmed: 27553644
Implement Sci. 2017 Mar 4;12(1):30
pubmed: 28259168
Int J Nurs Stud. 2018 Mar;79:86-93
pubmed: 29220738
J Med Internet Res. 2015 Jan 30;17(1):e30
pubmed: 25639757
Science. 2008 Sep 5;321(5894):1298-9
pubmed: 18772421

Auteurs

Katrina M Turner (KM)

Bristol Medical School, University of Bristol, Bristol, UK.

Nikki Rousseau (N)

Newcastle University Faculty of Medical Sciences, Newcastle upon Tyne, Newcastle upon Tyne, UK.

Liz Croot (L)

MCRU, School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.

Lucy Yardley (L)

Psychology, University of Southampton, Southampton, UK.
School of Health Sciences, University of Bristol, Bristol, UK.

Alicia O'Cathain (A)

School of Health and Related Research (ScHARR), The University of Sheffield, Sheffield, UK.

Pat Hoddinott (P)

Nursing, Midwifery and Allied Health Professional Research Unit, University of Stirling, Stirling, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH